PATENT CLAIM ANALYSIS

Application Number: 15919554
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "186100"]

Abstract:
Described herein is a method of enhancing virus replication in permissive cells that express a receptor to FGF2 protein. The method includes administering FGF2 protein or a functional variant thereof and the virus to the permissive cells. An oncolytic virus having a genome that includes an open reading frame that encodes FGF2 protein or a functional variant thereof is also described.

Claim (Index 14):
The isolated oncolytic virus particle according to  claim 7 , wherein the B18R protein comprises an amino acid sequence according to SEQ ID NO: 15.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 90.0
- Lexical Diversity: 1.64103
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14898083', '13060028', '13514837', '13937043', '12441494']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466974364429111
- 35 USC 102 Novelty (BERT): 0.6754014206145997
- Combined Prediction Score: 0.7395678348600799
- Mean Citation Score: 460.831728
- Max Citation Score: 813.16974
- Similarity Product: 636.1235872143674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test